Oana Danciu, Md

This study tested a combination of two drugs, palbociclib and tamoxifen, as the first treatment for people with a certain type of advanced breast cancer (hormone receptor positive, HER2 negative). The goal was to see how long the cancer could be kept from growing. 49 participants…